These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6390841)

  • 21. Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas J; Kasten-Jolly J; Verbanac K; Smith JP; Carver M; Gross U; Rebellato L; Thomas F; Haisch C
    Transplant Proc; 1995 Feb; 27(1):686-8. PubMed ID: 7879146
    [No Abstract]   [Full Text] [Related]  

  • 22. B-lymphocyte and kidney cell cross-reactive antibodies eluted from rejected human renal allografts.
    Mohanakumar T; Siegel W; Mendez G; Kaplan AM; Lee HM
    Transplant Proc; 1979 Dec; 11(4):1896-8. PubMed ID: 394434
    [No Abstract]   [Full Text] [Related]  

  • 23. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
    Delgado JC; Eckels DD
    Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
    House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
    Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against cultured B-cell lines in renal transplant recipients.
    Akiyama N; Mori T; Kusaba R; Inou T; Samaru Y; Kawamura A
    Jpn J Exp Med; 1979 Feb; 49(1):85-7. PubMed ID: 381733
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of prospective matching for HLA-DR on renal allograft survival in a single center.
    Goeken NE; Thompson JS; Corry RJ
    Transplantation; 1981 May; 31(5):397-9. PubMed ID: 7015630
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-HLA antibodies following the transplantation of highly sensitised renal allograft recipients.
    Palmer A; Bewick M; Kennedy L; Welsh K; Taube D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):766-7. PubMed ID: 2650263
    [No Abstract]   [Full Text] [Related]  

  • 28. MLR inhibitory activity of pretransplant anti-donor B cell antibodies, and kidney graft survival.
    Lenhard V; Diehm H; Rettwitz W; Dreikorn K
    Proc Eur Dial Transplant Assoc; 1981; 18():433-8. PubMed ID: 6460245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches.
    Noreen HJ; van der Hagen E; Bach FH; Fryd D; Ascher N; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 1):780-1. PubMed ID: 3274873
    [No Abstract]   [Full Text] [Related]  

  • 30. Most positive B cell crossmatches are not caused by anti-HLA-DR antibodies.
    d'Apice AJ; Tait BD
    Transplantation; 1980 Nov; 30(5):382-3. PubMed ID: 7006169
    [No Abstract]   [Full Text] [Related]  

  • 31. Important of HLA matching in cadaveric renal transplantation. A prospective one-center study.
    Moen T; Flatmark A; Jervell J; Dahl O; Halvorsen S; Solheim B; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():64-71. PubMed ID: 6815795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warm B-cell antibodies and DRw matching: their influence on transplant outcome at a single center.
    Coxe-Gilliland R; Cross DE
    Transplant Proc; 1981 Mar; 13(1 Pt 2):945-8. PubMed ID: 7022967
    [No Abstract]   [Full Text] [Related]  

  • 36. The implications of HLA-DR match for the outcome of cadaveric renal transplantation.
    Berg B; Groth CG; Klintmalm G; Lundgren G; Möller E
    Scand J Urol Nephrol Suppl; 1980; 54():29-31. PubMed ID: 7013037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative cyclosporine: interaction with multifactorial variables and effect on allograft function.
    Mendez R; Koussa N; Alanizi A; Mendez RG; Iwaki Y; Bogaard TP; Khetan U
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):12-5. PubMed ID: 3515677
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA-DR antigens on CLL lymphocytes.
    Johnstone AP
    Br J Haematol; 1982 Feb; 50(2):378-9. PubMed ID: 6977375
    [No Abstract]   [Full Text] [Related]  

  • 39. Probable role of suppressor cells and factors in kidney graft survival.
    Bensussan A; Klatzmann D; Gluckman JC; Kalil J; Dausset J; Sasportes M
    Transplant Proc; 1982 Sep; 14(3):584-7. PubMed ID: 6217608
    [No Abstract]   [Full Text] [Related]  

  • 40. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft.
    Middleton D; Martin J; Douglas J; McClelland M
    Transplantation; 1994 Oct; 58(7):845-8. PubMed ID: 7940720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.